Trihexyphenidyl Hydrochloride

Basic Information

Item Value
DrugBank ID DB00376
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 76

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 attention deficit-hyperactivity disorder KG + DL
2 faciodigitogenital syndrome KG + DL
3 attention deficit hyperactivity disorder, inattentive type KG + DL
4 Rasmussen subacute encephalitis KG + DL
5 PLA2G6-associated neurodegeneration KG + DL
6 congenital disorder of glycosylation with defective fucosylation KG + DL
7 polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis KG + DL
8 retinal dystrophy with or without extraocular anomalies KG + DL
9 myelitis KG + DL
10 Charcot-Marie-Tooth disease, demyelinating, type 1G KG + DL
11 atypical glycine encephalopathy KG + DL
12 myopia 26, X-linked, female-limited KG + DL
13 specific developmental disorder KG + DL
14 myopia X-linked KG + DL
15 transaldolase deficiency KG + DL
16 syndromic myopia KG + DL
17 schizophrenia KG + DL
18 fructose-1,6-bisphosphatase deficiency KG + DL
19 progressive supranuclear palsy-corticobasal syndrome KG + DL
20 hydranencephaly (disease) KG + DL
21 paralysis agitans, juvenile, of Hunt KG + DL
22 Lewy body dementia KG + DL
23 X-linked intellectual disability-ataxia-apraxia syndrome KG + DL
24 X-linked intellectual disability-cerebellar hypoplasia syndrome KG + DL
25 chondromyxoid fibroma KG + DL
26 CLCN4-related X-linked intellectual disability syndrome KG + DL
27 X-linked intellectual disability-spastic quadriparesis syndrome KG + DL
28 syndromic X-linked intellectual disability Chudley-Schwartz type KG + DL
29 X-linked intellectual disability with hypopituitarism KG + DL
30 X-linked cerebral-cerebellar-coloboma syndrome syndrome KG + DL
31 X-linked spasticity-intellectual disability-epilepsy syndrome KG + DL
32 hydrocephaly-cerebellar agenesis syndrome KG + DL
33 intellectual disability, X-linked, syndromic KG + DL
34 Paganini-Miozzo syndrome KG + DL
35 Prieto syndrome KG + DL
36 X-linked intellectual disability-hypotonia-movement disorder syndrome KG + DL
37 X-linked intellectual disability, Stocco dos Santos type KG + DL
38 lethal infantile mitochondrial myopathy KG + DL
39 intellectual developmental disorder, X-linked, syndromic, Hackmann-Di Donato type KG + DL
40 NAA10-related syndrome KG + DL
41 X-linked intellectual disability-precocious puberty-obesity syndrome KG + DL
42 MED12-related intellectual disability syndrome KG + DL
43 X-linked intellectual disability-craniofacioskeletal syndrome KG + DL
44 Basilicata-Akhtar syndrome KG + DL
45 holoprosencephaly 13, X-linked KG + DL
46 focal, segmental or multifocal dystonia KG + DL
47 lissencephaly type 1 due to doublecortin gene mutation KG + DL
48 X-linked intellectual disability-acromegaly-hyperactivity syndrome KG + DL
49 oromandibular dystonia KG + DL
50 dystonia, focal, task-specific KG + DL

(Showing top 50 of 76 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.